Toll-Like Receptors (TLRs)

Toll-Like Receptors (TLRs): Simplified Overview

Toll-like receptors (TLRs) are proteins that play a crucial role in the innate immune system, which is the body’s first line of defense against infections. TLRs act as pattern recognition receptors (PRRs), meaning they identify specific molecules associated with pathogens (PAMPs) or signals from damaged cells (DAMPs). Once activated, they trigger immune responses to protect the body.

Structure and Location

• Structure: TLRs have three parts:

1. Extracellular domain: Recognizes and binds to PAMPs or DAMPs.

2. Transmembrane domain: Anchors the receptor to the cell membrane or endosomes.

3. Cytoplasmic TIR domain: Initiates signaling inside the cell.

• Location:
• Cell surface TLRs (e.g., TLR1, TLR2, TLR4): Detect molecules like bacterial lipopolysaccharide (LPS).
• Endosomal TLRs (e.g., TLR3, TLR7, TLR9): Recognize viral or bacterial nucleic acids.

Function and Signaling

When TLRs detect a pathogen or damage signal, they activate signaling pathways via proteins like MyD88 or TRIF, leading to:

1. NF-κB activation: Produces inflammatory cytokines (e.g., TNF-α, IL-1β).

2. IRF activation: Produces antiviral interferons (e.g., IFN-α, IFN-β).

Clinical Relevance

• Gut Health: TLRs maintain intestinal barrier integrity but may contribute to diseases like IBD when dysregulated.
• Liver Diseases: In conditions like ALD or NAFLD, TLR4 is activated by bacterial LPS, causing inflammation and fibrosis.
• Therapeutic Potential: Drugs targeting TLRs, such as TLR4 inhibitors, and gut microbiome modulation are promising treatments for inflammatory and liver diseases.

TLRs are essential for immunity, but their overactivation can lead to chronic inflammation and disease progression.